Professor Shi Ruihua's team of early screening of esophageal cancer has re -achieved new results

Recently, the full text of "Cancer Medicine" published the latest research results of the new research results of the Southeast University Institute of Gastroenterology, Professor Shi Ruihua, Zhongda University Affiliated to Southeast University, and Chairman Feng Yadong. Research papers for the study of epithelial tumor as a study of the diagnosis threshold of early esophageal squamous carcinoma ".

At this point, the relevant research on early screening of new esophageal cytology, the team of Professor Shi Ruihua, and Feng Yadong, the Institute of Gastroenterology, Southeast University, Professor Shi Ruihua, and Feng Yadong, affiliated to Southeast University, have published three research results in the SCI journal No. 1 "Early screening technology of esophageal cancer cytology has received long -term attention from the international academic community.

Esophageal cancer is one of the main malignant tumors that seriously threaten the lives and health of our residents. The World Health Organization data shows that more than half of the new esophageal cancer cases in the world are concentrated in China. In 2020, the number of new cases of global esophageal cancer exceeded 600,000, and 324,000 new cases of esophageal cancer in my country, accounting for about 55%, ranking first in the world.

Action of Health China (2019-2030) "clearly stated that early screening, early diagnosis, early treatment, reducing the incidence and mortality of cancer, and improving the quality of survival of patients. Esophageal cancer is the second malignant tumor except pancreatic cancer. However, after early discovery and treatment, the 5 -year survival rate is greater than 95%. At present, a number of studies have shown that screening for high -risk people for esophageal cancer can effectively reduce the incidence and mortality of esophageal cancer. Therefore, carrying out screening and realizing early diagnosis and early treatment is a key measure to curb the high incidence of esophageal cancer in my country and reduce mortality for esophageal cancer.

In June 2022, he was commissioned by the National Health and Health Commission and led by the National Cancer Center. The joint multi -disciplinary experts jointly formulated and released the "Guidelines for the screening and early treatment of Chinese esophageal cancer (2022, Beijing)". The guide clearly states: The use of new esophageal cell collectors to collect and perform the preliminary sieve of esophageal cancer before endoscopy, which is currently the only solid evidence and efficient non -invasive method.

The "Food Kang No. 1" esophageal cancer lens before cytology screening technology is not only the only precise and effective early screening technology of esophageal cancer, but also an important exploration of improving the innovation path of regional cancer prevention and control. The key step is of great significance to reduce the burden on the treatment of malignant tumors in my country. (Edit Wang Qian Editor Cheng Shouqin)

- END -